European Federation of Pharmaceutical Industries and Associations
Page Module:Message box/ambox.css has no content.Page Template:Multiple issues/styles.css has no content.
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
Page Module:Message box/ambox.css has no content.
|
Page Module:Infobox/styles.css has no content.
European Federation of Pharmaceutical Industries and Associations | |
| Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found. | |
| Script error: No such module "Infobox mapframe". | |
| Formation | 1978 |
|---|---|
| Founded at | Brussels, Belgium |
| Purpose | Trade association |
| LocationTemplate:Pluralize from text | Page Template:Plainlist/styles.css has no content.
|
Region served | Europe |
| Members | 37 national associations, 55 corporate members |
Key people | Nathalie Moll (General Director) Lars Fruergaard Jørgensen (Chairman of the Board) |
| Staff | 60 (2023) |
| Website | www |
Script error: No such module "Check for conflicting parameters".
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is a Brussels-based trade association and lobbying organisation, founded in 1978, it represents the pharmaceutical industry in Europe. It consists of 36 national associations, 40 pharmaceutical companies and "a growing number" of Small and medium enterprises [1][2].
EFPIA priorities
EFPIA priorities include speeding up regulatory approval and reimbursement processes for new medicines, creating a strong science base in Europe, joining forces with key stakeholders on political issues concerning health and addressing safety concerns. EFPIA also includes specialised groups like Vaccines Europe[3] who produce approximately 80% of vaccines used worldwide and European Biopharmaceutical Enterprises harness biotechnology to develop approximately one-fifth of new medicines.
Innovative Medicines Initiative
The Innovative Medicines Initiative (IMI) is a public-private partnership designed by the European Commission and EFPIA. It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities. The initiative aims to accelerate the discovery and development of better medicines by removing bottlenecks in the drug development process. It focuses on creating better methods and tools to improve and enhance the drug development process, rather than developing specific, new medicines.
Controversy
From 1991 to 1998 Emer Cooke worked for the EFPIA.[4] She became executive director of the European Medicines Agency (EMA), an agency of the European Union (EU) in charge of the evaluation and supervision of medicinal products, in November 2020.[5]
In a session of the Austrian Parliament member of parliament Gerald Hauser on 1 April 2021 publicly criticised a potential conflict of interest, by her allowing the controversial Oxford–AstraZeneca COVID-19 vaccine to be approved, while having worked for the very same industry in the past as a lobbyist of the EFPIA.[6][7]
See also
- European and Developing Countries Clinical Trials Partnership (EDCTP)
- EuropaBio
- European Federation of Biotechnology (EFB)
- International Federation of Pharmaceutical Manufacturers Associations (IFPMA)
- Pharmaceutical Research and Manufacturers of America (PhRMA)
References
- ^ Page Module:Citation/CS1/styles.css has no content."Board & Working Parties". www.efpia.eu. Retrieved 2023-04-05.
- ^ Page Module:Citation/CS1/styles.css has no content."Who we are". www.efpia.eu. Retrieved 2026-02-12.
- ^ Page Module:Citation/CS1/styles.css has no content."Vaccines Europe".
- ^ Page Module:Citation/CS1/styles.css has no content."WHO | Emer Cooke". www.who.int. Archived from the original on 28 June 2020. Retrieved 15 January 2022.
- ^ Page Module:Citation/CS1/styles.css has no content."Emer Cooke takes office as head of EMA | European Medicines Agency". 16 November 2020.
- ^ Page Module:Citation/CS1/styles.css has no content."FPÖ – Hauser: EMA-Direktorin hat ihr ganzes Arbeitsleben mit Lobbying für die Pharmaindustrie verbracht | Freiheitlicher Parlamentsklub - FPÖ, 01.04.2021".
- ^ Archived at Ghostarchive and the Wayback Machine: Page Module:Citation/CS1/styles.css has no content."Gerald Hauser zeigt Brisantes über die Impfstoffzulassung auf!". YouTube.
External links
- Official website of the European Federation of Pharmaceutical Industries and Associations – (EFPIA)
- Innovative Medicines Initiative (IMI)
- Vaccines Europe (VE)
- European Biopharmaceutical Enterprises (EBE) (archived)
Lua error in package.lua at line 80: module 'Module:Authority control/config' not found.
